The Cushing Syndrome Conundrum: Diagnosing and Managing a Silent Driver of Hypertension

In this recent Medscape InDiscussion podcast Dr. Marwah Abdalla welcomes PWN’s Dr. Lewis Blevins to talk about secondary hypertension. This episode focuses on Cushing syndrome, an often overlooked cause of secondary hypertension. We’ll discuss why

When your pituitary endocrinologist writes science fiction: introducing “2345”

When you visit Pituitary World News or Adrenal World News, you expect to find science and medical articles, patient-oriented books, podcasts and videos about pituitary and adrenal conditions, and expert opinions on current treatments, advocacy

From Discovery to Delivery: Crinetics Co-Founders on the Journey to Bring new drugs to Patients

In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.

Inside Camurus: Dr. Markus Johnsson talks about FluidCrystal® technology and next-generation treatment innovations

In the latest episode of the Pituitary World News podcast, Jorge D. Faccinetti sits down with Dr. Markus Johnsson, Senior VP of R&D at Camurus, to explore the fascinating world of FluidCrystal® technology. This innovative approach promises to revolutionize the way we think about drug delivery, providing long-lasting solutions for chronic diseases particularly for people with acromegaly.

Announcing Adrenal World News and new e-magazine for the adrenal world

FOR IMMEDIATE RELEASE: San Francisco – Friday, December 5, 2025 – Pituitary World News announced the launch of Adrenal World News, a new e-magazine dedicated to raising awareness of adrenal conditions which affect approximately 11 to 12 million people worldwide. Adrenal World News operates as a subsidiary of Pituitary World News

New 3-Month Octreotide Formulation Enters Phase 3 Testing for Acromegaly

In an important new development Swiss-based Debiopharm entered a Phase 3 trial of a new Octreotide formulation. The company is currently recruiting patients for the study. Debio 4126 is a sustained-release formulation designed to improve the convenience of somatostatin analogue​ (SSA) therapy for the treatment of acromegaly.

Beyond the tumor: The hidden struggles with sexual health and suicide risk

What does not get discussed has more power to instill fear, promote untruths, and deepen hurt and pain. Even in our modern Western culture, many myths and misinformation surround both the topics of sex and suicide, so I thought it was time to begin to explore and try to understand both here, as difficult as it may be to address.

Un sistema de reconocimiento facial con IA detecta la acromegalia 10 años antes del diagnóstico

¿Podría la inteligencia artificial y la tecnología de aprendizaje automático reconocer los cambios sutiles y tempranos que se producen en los rostros de las personas con la enfermedad hormonal acromegalia? Una nueva investigación encabezada por